EAGAN, Minn., Aug. 14, 2025 – ABM Respiratory Care, a global medical technology company focused on developing and marketing innovative solutions for respiratory care, today announced the Canadian launch of its next-generation assisted-cough system, BiWaze® Cough, through its exclusive distribution partner, McArthur Medical Sales Inc.
BiWaze Cough is designed to help patients with a weak or ineffective cough remove secretions more efficiently, combining patient comfort with advanced therapy delivery. With McArthur Medical’s coast-to-coast respiratory expertise, clinicians and patients across Canada will have access to local product support, clinical training, and service from day one.
“We are excited to bring BiWaze Cough to patients and clinicians across Canada,” said Leah Noaeill, VP of Marketing and Clinical Affairs at ABM Respiratory Care. “Our partnership with McArthur Medical ensures that customers will benefit not only from cutting-edge therapy technology but also from a trusted, responsive support team that understands the needs of the respiratory care community.”
Key features of BiWaze Cough include:
- Dual-blower with dual-lumen breathing circuit – separates airflow pathways so exhaled mucus is not mixed with fresh inhaled air
- Steady insufflation ramp and strong peak cough flow – designed for comfort and effective secretion clearance
- Positive pressure during the pause phase – helps maintain lung volume throughout therapy
- Personalized clinical support – on-site training and service from McArthur Medical’s experienced respiratory team
BiWaze Cough is now available for hospital and home-care programs nationwide in Canada. Healthcare providers interested in learning more can contact McArthur Medical Sales or visit https://mcarthurmedical.com/.
About ABM Respiratory Care
Founded in 2017, ABM Respiratory Care is dedicated to advancing patient care by developing intelligent, clinically differentiated respiratory care solutions to help people breathe better inside and outside the hospital. The company’s connected platform is designed to improve respiratory therapy by promoting deeper breathing, enhancing oxygen exchange, reducing aerosol emission exposure, and enabling communication for better disease management across all care settings. For more information, visit www.abmrc.com.
About McArthur Medical Sales Inc.
Established in 1984, McArthur Medical is a Canadian leader in medical devices for neonatal, anesthesia, and respiratory care. McArthur Medical meets the requirements of current regulatory standards for medical devices set by Health Canada and the U.S. FDA, holding MDSAP / ISO 13485:2016 certification for its Quality Management System (QMS). To learn more, visit https://mcarthurmedical.com/.
Investor and Media Contact:
Leah Noaeill
VP of Marketing and Clinical Affairs
ABM Respiratory Care
Leah.Noaeill@ABMRC.com
1.877.226.7201